News & Events

In this section

Leading CRO Chooses Instem Software Solutions for Global Multi-Site Deployment

Instem's Provantis Preclinical Study Management and submit-SEND solutions Chosen by International Contract Research Organization

CONSHOHOCKEN, PA - (BUSINESS WIRE) – April 10, 2014 - -Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that a leading international contract research organization has purchased the Provantis® software suite for managing their preclinical studies, along with the submit™ solution suite to support CDISC’s Standard for Exchange of Nonclinical Data (SEND).

SEND defines the organization, structure, and format of standard nonclinical tabulation datasets for interchange between organizations such as sponsors and contract research organizations and for submission to the US Food and Drug Administration (FDA).

The client provides a comprehensive range of preclinical and specialty services from facilities across Europe and North America. Together with its global partner network it also provides clinical bioanalysis, embryonic stem cell biomarker discovery and customized preclinical efficacy model services.

Following an industry merger, the client, who was already using Provantis at a number of sites, re-evaluated the preclinical market as they looked to automate all of their combined sites covering a wider application area. This included a requirement for a solution that could convert data from any source system into SEND files and allow sponsors, CRO’s and regulators to share, visualize and analyze study data more efficiently.

Key Facts

  • Client to deploy entire suite of Provantis version 9
  • Submit™ solution chosen to create, convert, visualize and share SEND data
  • Purchase includes the Provantis Portal for remote study monitoring
  • Instem chosen for global market leadership, stability and regional support center coverage

“We are very encouraged to see another client enhance and expand their use of our solution suites within preclinical,” comments John Anderson-Carter, VP Sales at Instem. “Our client joins a roster of leading organizations turning to Instem to help further streamline their processes and increase the quality of study data while enabling seamless coordination between study partners and sponsors.”

About Instem

Instem is a leading supplier of IT applications to the early development healthcare market, delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.

Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.

Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.

Meeting clients at the intersection of investment & return™.

Press Contacts:

Gary Mitchell (US HQ)
Tel: 610-941-0990

Julie Jones (UK HQ)
Tel: +44 (0) 1785 825600